Italia markets closed

BMY Jan 2026 30.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,0000-0,0800 (-7,41%)
In data: 09:33AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente1,0800
Aperto1,0000
Denaro0,9400
Lettera1,1400
Prezzo d'esercizio30,00
Scadenza2026-01-16
Min-Max giorno1,0000 - 1,0000
Contratto - Min-MaxN/D
Volume1
Open Interest1,23k
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri